Regulatory Documentation

Expert Regulatory Documentation

High-quality documentation is the foundation of a successful regulatory submission. Our team of expert writers and regulatory professionals ensures that your documents are clear, concise, and compliant with all applicable guidelines.

We understand that regulatory submissions must meet rigorous standards while clearly communicating the safety and efficacy of your product. Our documentation services span the entire product lifecycle, from initial development through post-approval maintenance.

Document Types

• INDs/CTAs: Investigational New Drug applications and Clinical Trial Applications that enable you to begin clinical studies.
• NDAs/BLAs/MAAs: Marketing applications for US and EU markets, prepared in full compliance with current guidance.
• Investigator Brochures: Comprehensive summaries of clinical and nonclinical data that investigators need to conduct trials safely.
• Briefing Books: Strategic briefing documents for health authority meetings that frame discussions favorably.
• DMFs & ASMFs: Drug Master Files and Active Substance Master Files for drug substance and excipient manufacturers.

Our Documentation Process

Every project begins with a detailed kickoff meeting to understand your product, timeline, and specific requirements. We develop a documentation plan that outlines deliverables, milestones, and review cycles.

Our writers work from templates aligned with FDA, EMA, and ICH guidelines. We maintain consistency across modules and sections, ensuring a cohesive submission that facilitates efficient agency review.

Quality Assurance

All documents undergo multiple rounds of quality control before delivery. We verify scientific accuracy, regulatory compliance, and editorial consistency. Our QC process includes hyperlink verification, cross-reference checking, and format validation.

We also provide publishing services for eCTD submissions, ensuring your electronic dossiers are technically valid and viewer-ready.